Abstract
The effects of benztropine, scopolamine, atropine, methylatropine, amitriptyline, phencyclidine, and meperidine were determined alone and in conjunction with a behaviourally suppressing dose (0.05 mg/kg IM) of oxotremorine in pigeons responding under a multiple fixed-ratio 30 fixed-interval 5-min schedule of grain presentation. Benztropine, scopolamine, atropine, and amitriptyline antagonized the behavioral suppressing effects of oxotremorine at doses that alone decreased responding. In contrast, methylatropine, phencyclidine, and meperidine did not antagonize the effects of oxotremorine. These results suggest that benztropine, scopolamine, atropine, and amitriptyline decrease responding due to an action at central muscarinic receptors, whereas the behavioral effects of methylatropine, phenyclidine, and meperidine are due to actions other than at central muscarinic receptors.
Similar content being viewed by others
References
Adams PM (1980) Interaction of phencyclidine with drugs affecting cholinergic neurotransmission. Neuropharmacology 19:151–153
Bianchine JR (1980) Drugs for Parkinsons' disease: Centrally acting muscle relaxants. In: Gilman AG, Goodman LS, Gilman A (eds) Pharmacological basis of therapeutics. MacMillan, New York, pp 475–493
Carter RB, Harden TK, Leander JD (1980) Effect of meperidine and analogues on 3H-quinuclidinyl benzilate (3H-QNB) binding in rat brain. Pharmacologist 22:305
Chait LD, Balster RL (1979) Effects of phencyclidine, atropine and physostigmine, alone and in combination, on variable-interval performance in the squirrel monkey. Pharmacol Biochem Behav 11:37–42
Ferster CD, Skinner BF (1957) Schedules of reinforcement. Appleton-Century-Crofts, New York
Fjalland B, Christensen AV, Hyttel J (1977) Peripheral and central muscarinic receptor affinity of psychotropic drugs. Naunyn-Schmiedeberg's Arch Pharmacol 301:5–9
Glick SS, Cox RD, Maayani S, Meibach RC (1979) Anticholinergic behavioral effect of phencyclidine. Eur J Pharmacol 59:103–106
Golds RP, Przyslo FR, Strange PG (1980) The binding of some antidepressant drugs to muscarinic acetylcholine receptors. Br J Pharmacol 68:541–549
Inch TD, Green DM, Thompson PBJ (1973) The central and peripheral activities of anti-acetylcholine drugs. Some concepts of practical relevance. J Pharma Pharmacol 25:359–370
Kopera J, Armitage AK (1954) Comparison of some pharmacological properties of chlorpromazine, promethazine and pethidine. Br J Pharmacol Chemother 9:392–401
Leander JD (1979) Meperidine does not block the cholinergic effects of oxotremorine. Pharmacol Biochem Behav 10:941–942
Leander JD, McMillan DE (1977) Meperidine effects on schedule-controlled responding. J Pharmacol Exp Ther 201:434–443
Rathbun RC, Slater IH (1963) Amitriptyline and nortriptyline as antagonists of central and peripheral cholinergic activation. Psychopharmacologia 4:114–125
Rehavi M, Maayani S, Sokolovsky M (1977) Tricyclic antidepressants as antimuscarinic drugs. In vivo and in vitro studies. Biochem Pharmacol 26:1559–1567
Taylor P (1980) Anticholinesterase agents. In Gilman AG, Goodman LS, Gilman A (eds) Pharmacological basis of therapeutics. Mac Millan, New York, pp 100–119
Vaillant GE (1964) Antagonism between physostigmine and atropine on the behavior of the pigeon. Naunyn-Schmiedebergs Arch Exp Path Pharmak 248:406–416
Vaillant GE (1967) A comparison of antagonists of physostigmine-induced suppression of behavior. J Pharmacol Exp Ther 157:636–648
Vincent JP, Cavey D, Kamenka JM, Geneste P, Lazdunski M (1978) Interaction of phencyclidines with muscarinic and opiate receptors in the central nervous system. Brain Res 152:176–182
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leander, J.D. Antagonism of oxotremorine-induced behavioral suppression by antimuscarinic drugs. Psychopharmacology 75, 5–8 (1981). https://doi.org/10.1007/BF00433492
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00433492